Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol.

Chin Med J (Engl)

Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing 400036, China.

Published: May 2020

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213617	PMC
http://dx.doi.org/10.1097/CM9.0000000000000790	DOI Listing

Publication Analysis

lopinavir/ritonavir interferon-alpha

comparative effectiveness

effectiveness safety

safety ribavirin

ribavirin interferon-alpha

interferon-alpha lopinavir/ritonavir

interferon-alpha ribavirin

ribavirin lopinavir/ritonavir

interferon-alpha patients

patients mild

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!